Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Daiichi Sankyo Co Ltd to Apply for Marketing Approval for Anti-influenza Agent Inavir-Chemical Daily


Sunday, 18 Nov 2012 07:00pm EST 

Chemical Daily reported that Daiichi Sankyo Co Ltd announced that is has submitted an application to Ministry of Health, Labor and Welfare, applying for the manufacturing and marketing approval of its anti-influenza agent inavir. 

Company Quote

1613.5
-5.5 -0.34%
30 Oct 2014